调脂汤治疗酒精性脂肪肝的临床分析

Clinical analysis of lipid treating alcoholic fatty liver

目的本文通过对调脂汤与水飞蓟宾两组药物对照研究,对调脂汤治疗酒精性脂肪肝进行疗效评定,为其进一步临床应用提供依据。方法应用肝功、血脂、B超等现代检测手段,并采用随机、对照原则对调脂汤进行疗效评定。结果两组内肝功主要指标治疗前后均有改善,差异均有统计学意义(P<0.05);两组间治疗后AST、ALP差异有统计学意义(P<0.05),而ALT、GGT比较差异无统计学意义(P>0.05)。两组内治疗前后TG,CH比较均有改善,差异均有统计学意义(P<0.05);两组治疗后TG比较差异有统计学意义(P<0.05),CH值比较无统计学意义(P>0.05)结论调脂汤治疗酒精性脂肪肝与对照组相比表明调脂汤治疗酒精性脂肪肝临床效果理想,可进一步推广应用。

Objective Based on the lipid soup with silibinin two drugs control study lipid treating alcoholic fatty liver for efficacy evaluation, to provide the basis for further clinical applications. Methods liver function, blood lipids, B ultrasonic modern detection methods, and the use of randomized, controlled principle Tiaozhi soup efficacy evaluation.Results The main indicators of liver function in two groups before and after treatment were improved, the differences were statistically significant （P 〈0.05）; between the two groups after treatment, AST, ALP difference was statistically significant （P 〈0.05）, while ALT, GGT the difference was not statistically significant （P〉 0.05）. Within the two groups before and after treatment TG, CH compare both improved differences were statistically significant （P 〈0.05）; TG after treatment was statistically significant difference （P 〈0.05）, CH value was not statistically significant （P〉 0.05） Conclusion Tiaozhi treating alcoholic fatty liver compared with the control group showed that lipid treating alcoholic fatty liver clinical results are satisfactory, can further promote the apl31ication.